OMB control number
Expedited Programs for Serious Conditions-Drugs and Biologics
OMB 0910-0765 · HHS/FDA.
OMB 0910-0765
This ICR collects information from sponsors and applicants who wish to obtain a priority review designation or breakthrough therapy designation. Respondents to the collection are manufacturers or sponsors of drug and/or biologic products.
The latest form for Expedited Programs for Serious Conditions-Drugs and Biologics expires 2028-03-31 and can be found here.
Latest Forms, Documents, and Supporting Material
Document Name |
|---|
Supporting Statement A |
All Historical Document Collections
| Revision of a currently approved collection | 2024-08-23 | ||
|
Withdrawn and continue |
Extension without change of a currently approved collection | 2024-07-22 | |
|
Withdrawn and continue |
Revision of a currently approved collection | 2024-04-18 | |
|
Approved without change |
Extension without change of a currently approved collection | 2021-03-26 | |
|
Approved without change |
No material or nonsubstantive change to a currently approved collection | 2018-09-25 | |
|
Approved without change |
Revision of a currently approved collection | 2018-02-13 | |
|
Approved without change |
Extension without change of a currently approved collection | 2017-03-15 | |
|
Approved without change |
New collection (Request for a new OMB Control Number) | 2013-12-31 |
OMB Details
Priority Review Designation Requests (Expedited Programs for Serious Conditions) - CDER
Federal Enterprise Architecture: Health - Consumer Health and Safety